
Opinion|Videos|December 16, 2024
Primary Treatment Goals for Patients With IgAN
Key Takeaways
- Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
- Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
Panelists discuss how the primary treatment goals for patients with IgA nephropathy evolve based on the stage of the disease, emphasizing the importance of tailoring strategies to individual patient needs.
Advertisement
Episodes in this series

- What are the primary treatment goals for patients with IgA nephropathy, and how do they evolve based on the stage of the disease?
Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease
2
STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD
3
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
4
Common Diuretic Linked to Home Blood Pressure Lowering After Stroke
5

